Luminoma

Auckland, NZ · 3 known investors

Luminoma is developing the LumAssure, a portable diagnostic-aid that uses Raman spectroscopy to non-invasively assess whether a skin lesion is likely malignant or benign within seconds. The device is intended to help clinicians make more objective skin cancer biopsy decisions and reduce unnecessary biopsies.